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Abstract 
Background: Brain iron is an essential as well as a toxic redox active element. Physiological levels are not uniform 
among the different cell types. Besides the availability of quantitative methods, the knowledge about the brain iron 
lags behind. Thereby, disclosing the mechanisms of brain iron homeostasis helps to understand pathological iron-
accumulations in diseased and aged brains. With our study we want to contribute closing the gap by providing quan-
titative data on the concentration and distribution of iron in neurons and glial cells in situ. Using a nuclear microprobe 
and scanning proton induced X-ray emission spectrometry we performed quantitative elemental imaging on rat 
brain sections to analyze the iron concentrations of neurons and glial cells.
Results: Neurons were analyzed in the neocortex, subiculum, substantia nigra and deep cerebellar nuclei revealing 
an iron level between (0.53± 2) and (0.68± 2)µM . The iron concentration of neocortical oligodendrocytes is fivefold 
higher, of microglia threefold higher and of astrocytes twofold higher compared to neurons. We also analyzed the 
distribution of subcellular iron concentrations in the cytoplasm, nucleus and nucleolus of neurons. The cytoplasm 
contains on average 73% of the total iron, the nucleolus—although a hot spot for iron—due to its small volume 
only 6% of total iron. Additionally, the iron level in subcellular fractions were measured revealing that the microsome 
fraction, which usually contains holo-ferritin, has the highest iron content. We also present an estimate of the cellular 
ferritin concentration calculating 133± 25 ferritin molecules per µm in rat neurons.
Conclusion: Glial cells are the most iron-rich cells in the brain. Imbalances in iron homeostasis that lead to neuro-
degeneration may not only be originate from neurons but also from glial cells. It is feasible to estimate the ferritin 
concentration based on measured iron concentrations and a reasonable assumptions on iron load in the brain.
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Background
A balanced iron regulation ensures that iron is kept in 
appropriate states and concentrations to fulfill its essen-
tial functions in the brain while its harmful effects remain 
controlled. Iron is essential as cofactor of numerous 
enzymes, especially for ATP production, myelination 
and synthesis of DNA, RNA, proteins and neurotrans-
mitters [1–3]. No other organ than the brain constantly 
needs readily available iron in a regional, cellular and age 
sensitive manner [2]. A failure to meet this demand for 
iron can result in persistent neurological and cognitive 
dysfunction. On the other hand, increased iron levels and 
iron accumulations in specific brain regions and cells are 
hallmarks for numerous neurodegenerative diseases, but 
also for the aging brain [1–7]. The prominent neurode-
generative diseases with an iron-associated pathology are 
Parkinson’s disease and Alzheimer’s disease, but there is 
also Huntington’s disease, Friedreich’s ataxia, multiple 
sclerosis, progressive supranuclear palsy, and the group 
of diseases referred to NBIA (neurodegeneration with 
brain iron accumulation). An overview of more than 15 
diseases is given by Dusek et al. [8].
Oxidative stress is suggested to be a key pathological 
feature of neurodegeneration and aging processes. Exces-
sive free iron increases the risk to generate highly reactive 
radicals such as hydroxyl radical via the Fenton reaction. 
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This stimulates oxidative stress and causes damage to 
DNA, proteins, lipids and can finally lead to cell death.
Nevertheless, the “too much” of iron, usually visual-
ized with magnetic resonance imaging (MRI) scans in 
individuals with neurological disorders, is not a simple 
statement per se. The iron metabolism probably dif-
fers between neurons, astrocytes, oligodendrocytes and 
microglia, as each of these cell types has distinct meta-
bolic and architectural features. Thus, the detected iron 
in the effected brain regions may not be increased in 
general, but is rather caused by iron accumulations and 
redistributions associated with certain cell types.
However, the spatial resolution of non-invasive tech-
niques like MRI does not permit the identification of 
specific cell types [9]. The numerous studies that inves-
tigate brain iron and the potential neurotoxicity of iron 
are mostly comparative studies and/or are based on data 
obtained with semiquantitative techniques. Semiquan-
titative techniques either require the addition of chela-
tors (Perls’ and Turnbull’s stain, ferrozine) or fluorescent 
probes to colorimetrically or photometrically analyze 
iron [10, 11], or they require sample homogenation (mass 
spectrometry, electron spin resonance spectroscopy, 
atom absorption spectroscopy) [12] which precludes 
analyses with spatial or cellular resolution. The number 
of techniques that are able to quantitatively determine 
the “natural” concentration of iron (and other elements) 
of single cells is limited. Reviews are given by McRae 
et al. [13] and Bourassa and Miller [14].
Besides the availability of quantitative methods, our 
knowledge about the brain iron metabolism lags behind 
our knowledge about systemic iron metabolism [9]. 
Thereby, a better understanding of the brain iron home-
ostasis would help to find the causes of the potentially 
pathological iron-accumulations in diseased and aged 
brains. With our study we want to contribute closing the 
gap by providing quantitative data on the concentrations 
and distributions of iron in neurons and glial cells in situ. 
A technique that meets the requirements for this task 
is quantitative elemental imaging with a nuclear micro-
probe that uses mega-electronvolt protons for scanning 
particle-induced X-ray emission microscopy ( µPIXE).
Results
Qualitative elemental analysis of subcellular fractions 
of brain homogenate
Fractions enriched in subcellular organelles (nucleus 
fraction, mitochondrion fraction, and microsome frac-
tion) of neocortex were obtained by differential cen-
trifugation. The contents of the elements P, S, Cl, K, Ca, 
Fe in the fractions were compared among the different 
fractions using their PIXE intensities (peak areas) in the 
charged-normalized PIXE spectra (Fig.  1). The specific 
energies EX of the X-ray fluorescence peaks of Fe are 6.4 
keV ( Kα ) and 7.1 keV ( Kβ).
The nucleus and mitochondrion fractions have a rela-
tive iron content of 8% and 15%, respectively. The rela-
tive iron content of the microsome fraction is 75%. The 
microsome fraction also shows the highest content for P, 
S and Ca, but the lowest concentration for Cl. The con-
tent of Cl and K are highest in the nucleus and mito-
chondrion fractions. The remaining supernatant of the 
differential centrifugation, the cytosolic fraction, con-
tains the lowest relative ion concentration of 2%.
PIXE quantitative elemental imaging of neurons
Neurons were identified in the element images by their 
P-rich cell somata. The high phosphorus concentration 
(Fig. 2 P-image) is due to the RNA-rich ribosomes. The 
sulphur image (Fig. 2 S-image) mainly shows the distri-
bution of the macromolecules of the extracellular matrix 
that are rich in sulphate groups.
We quantified the somatic iron concentrations of 142 
neurons in total, whereby only neurons distinctly show-
ing a nucleus were selected. We differentiated between 
neurons in the neocortex ( n = 60 ), subiculum ( n = 24 ), 
substantia nigra ( n = 46 ) and deep cerebellar nuclei 
( n = 12 ). The average iron concentrations of the neurons 
are (0.53± 02)mM , (0.68± 02)mM , (0.54 ± 02)mM , 
and (0.60± 02)mM , respectively (Fig.  3). In native, 
untreated cryosections the regional iron concentration is 
(0.58± 09mM . This shows, that the amount of iron that 
is possibly washed out during the preparation/staining 
procedure of the paraffin sections is insignificant for the 
results and can be neglected.
Neurons: iron concentrations in cytoplasm, nucleus 
and nucleolus
We further analyzed the iron concentrations of the sub-
cellular compartments cytoplasm, nucleus, and nucleo-
lus. The ROIs for the analysis were set in the P-image 
(Fig.  4a). Because only neurons clearly showing both, 
a nucleus and a nucleolus, neurons of all investigated 
regions were pooled to increase the related data set 
(Fig. 4).
The subcellular iron concentration of an “average 
neuron” is shown in Fig. 4b with iron concentrations of 
(0.57± 06)mM in the cytoplasm, (0.74 ± 02)mM in the 
nucleus, and (0.96± 05)mM in the nucleolus. We fur-
ther calculated the relative volume of the analyzed com-
partments to determine the ratio of the iron content of 
the cytoplasm, nucleus and nucleolus to the total iron 
content (Fig.   4b values to the right). Most of the cellu-
lar iron, (73± 17)% , is contained in the cytoplasm. The 
lowest contribution comes with (6± 1)% from the nucle-
olus, due to its small volume. Besides the different iron 
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contents in cytoplasm, nucleus and nucleolus, several 
neurons contained hot spots of iron within the cytoplasm 
as seen in Fig.  5. Such iron-rich cytoplasmic sites has 
been also observed in Perls’ stain (data not shown).
Glial cells: iron concentrations in astrocytes, 
oligodendrocytes, and microglia.
Astrocytes, oligodendrocytes, and microglia were identi-
fied with specific antibodies (see Methods section) and 
visualized due to their 3,3′-diaminobenzidine (DAB)-Ni-
labeling seen in the Ni-image (Fig. 6). The Ni-labeling is 
not only necessary to select specifically the type of glial 
cells, but also to highlight their soma. In contrast to neu-
rons the high phosphorus region in glial cells is restricted 
to the nucleus. The cytoplasm cannot be delineated in the 
P-image. The P-image can therefore not be used to define 
glial somata. Specific staining that also highlights the 
soma as seen in the Ni-image is required (Fig.   6 yellow 
arrows in the astrocyte images). The average intracellu-
lar iron concentration is (1.29± 14)mM for astrocytes, 
(1.76± 27)mM for microglia and (3.05± 16) mM for 
oligodendrocytes (Fig.    3). Comparing the iron concen-
tration of the different glial cell types, astrocytes and 
microglia do not differ significantly, whereby oligoden-
drocytes’ average iron concentration is significantly 
higher ( p < 0.001).
Iron concentration: neurons versus glial cells
The three types of glial cell, analyzed in the neocortex, 
contain generally more iron than neurons of any analyzed 
brain region ( p < 0.001 , Fig. 3). The average iron concen-
tration of oligodendrocytes is fivefold higher than that 
of neurons ( p < 0.001 ). Astrocytes have a twofold and 
microglia a threefold higher iron concentration than neu-
rons ( p < 0.001).
Discussion
Iron concentrations of neurons and glial cells
The neuronal and glial iron concentration was meas-
ured in  situ and thus represents a reasonable measure 
for the physiological state. There are only a few quanti-
tative studies on the cellular iron concentrations in the 
brain. Ortega et al. [15] used synchrotron radiation X-ray 
fluorescence (SRXRF) to quantify the iron content in 
a dopamine producing rat cell line (PC12) in  vitro. The 
cell bodies of the cells contained about (5.0± 17)ng/cm2 
iron (mean ±  SE; n  =  4–6) when cultured in iron free 
medium. Under excess iron condition, i.e. adding the 
subtoxic concentration of 0.3mM FeSO4 to the medium, 
the PC12 cells contained about 20 ng/cm2 in their cell 
bodies (mean ± SE; n = 4–6). In our in situ study of neu-
rons the iron concentration of (0.56± 02)mM converts 
to (15.6± 6) ng/cm2 (mean ± SE ; n = 142 ), which falls 
Fractional iron 
contribution 
Fig. 1 PIXE spectra of subcellular fractions. Particle induced X-ray emission spectra (charged-normalized) acquired from equal amounts of 
subcellular brain fractions of a neocortex from one rat. X-ray energy ( EX ) is specific for each element and thus used for elemental identification 
( EX of Fe: K α-line: 6.4 keV, Kβ-line: 7.1 keV). The PIXE intensity peak area is a measure for the element concentration. The iron concentration of the 
microsome fraction is much higher than of the other fractions (peak height of ≈ 800 vs. ≈ 100). The pie chart inset gives the relative contribution of 
each fraction to the total iron content of the neocortex homogenate
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between the iron depleted and excess limits observed by 
Ortega and coworkers.
Hare et al. [16] used laser ablation inductively-coupled 
plasma mass spectrometry (LA-ICP-MS) with the high 
resolution of 5µm to analyze the iron content in mice 
dopaminergic neurons in the substantia nigra and in 
the ventral tegmental area in  situ. They report on iron 
levels of around 12µg g−1 . Since they do not present 
the concentration in units of millimolar, a conversion is 
estimated based on the given information on the sam-
ple preparation: room temperature dried cryosections of 
30µm thickness. For dried cryosections of 30µm thick-
ness we have measured (for rat brain) a matrix mass of 
0.9mg/cm2 . With these assumptions Hare and cowork-
ers’ result of about 12µg g−1 of mice neurons converts to 
0.06mM . This is one order of magnitude lower than our 
results for rat neurons.
Our in  situ measurements revealed that oligoden-
drocytes have the highest iron concentration among 
the investigated brain cell types. This quantitative data 
(Fig. 3) are in line with the histochemical findings that oli-
godendrocytes are noticeably the most iron-rich cell type 
in the brain [17, 18]. It is assumed that the synthesis and 
maintenance of myelin, the major function of oligoden-
drocytes [19], requires high iron levels to cover enzymatic 
and metabolic needs. Furthermore, oligodendrocytes are 
likely to mediate iron regulation and are shown to be well 
equipped with iron storage and transport proteins [20]. 
This correlates with the high iron content measured in 
these cells. Oligodendrocytes play a neuroprotective and 
supportive role or, in case of dysfunction, might initi-
ate or progress the degeneration process (for review see 
[21]). For example, in mice deficient for iron-responsive 
element, a model of neurodegeneration due to abnormal 
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Fig. 2 Quantitative element maps. Element images of P, S, Ca, Cu, and Fe. The element images were used to extract the average concentrations 
from regions of interest. The somata of the neurons are visible due to their high phosphorus content (P image). The extracellular matrix is rich in 
sulfur (S image). Within the region of the neurons (N), the iron map shows elevated iron level in the somata and the hot spot in the nucleolus. The 
three bright phosphorus spots (top, center, and right in the P-map) are glial cells (G) with high iron concentrations
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iron regulation, oligodendrocytes show a multi-fold 
increase in ferritin amount while surrounding degenerat-
ing neurons have a multi-fold decrease [22].
For astrocytes, Hoepken et  al. [23] used atomic 
absorption spectroscopy (AAS) to measure the iron 
content in lysate of cultured rat astrocytes. They 
used Dulbecco’s Modified Eagle’s Medium (DMEM), 
which contains 0.25µM iron in the form of fer-
ric nitrate. Normalized to the protein content they 
received (9.3± 5) nmoliron/mgprotein (mean ± SE ; 
SD = 1.2 nmoliron/mgprotein , n = 6 cultures). This com-
pares well in the order of magnitude with our in  situ 
results of (5.9± 8) nmoliron/mgprotein . For the conversion 
we need to rely on an estimate of the protein content and 
cellular mass density. We used for the protein content 
20% by weight [24] and a 1.1 g/cm3 for the density. An 
alternative way for the conversion of our result uses the 
average cytosolic volume of cells in astrocyte-rich cul-
tures, which has been estimated by the 3-O-methylglu-
cose method to be (4.1± 1)µL/mgprotein [25]. Therewith, 
our result for the astrocytes’ iron content converts to 
(5.3± 6) nmoliron/mgprotein . Another study on the iron 
content of astrocytes in  vitro, which were derived from 
newborn mice, was published by Bishop et al. [26]. Using 
a ferrozine-based colorimetric assay they calculated, 
based on protein content and estimated cytosolic vol-
ume, an intracellular iron concentration of (1.2± 6)mM 
(mean ± SD; n ≥ 3 cultures). Within the margin of errors, 
the iron concentration of mice primary astrocytes pub-
lished by Bishop and coworkers is the same as we meas-
ured for rat astrocytes in situ ((1.29± 14)mM).
However, due to the lack of knowledge on the cyto-
solic volume of neurons and microglia, [26] were not able 
to calculate the iron concentration for these cell types. 
Though, they found microglia and astrocytes to accu-
mulate more iron than neurons, whereby microglia was 
most efficient. Comparing this with our results where 
microglia have the tendency ( p < 0.07 ) to contain more 
iron than astrocytes, and that neurons have the lowest 
iron content, similarities are obvious. In our data, neu-
rons in neocortex, substantia nigra, subiculum, and deep 
cerebellar nuclei show the same iron concentration, but 
glial cells do not only contain more iron than neurons, 
but also show a different iron concentration depending 
on the type of glial cell. Therefore, we speculate that the 
iron concentration depends more on the neural cell type 
and on the metabolic characteristics and functions of the 
cell than on the brain region the cell is located in.
Indeed, even that brain cells express a similar set of iron 
proteins, the amount of each protein expressed varies 
Fig. 3 Diagram of intracellular iron concentrations. Intracellular iron concentration (mM) of neurons and glial cells (astro = astrocytes, 
micro = microglia, oligo = oligodendrocytes) in different brain regions. Control measurements of the investigated regions in native, untreated 
cryosections proofs that the iron concentration is not effected by the preparation/staining procedure. n = number of cells. Values are given as 
mean ± SE. Statistics: Q–Q-plot, t-test. Significance: * p < 0.001
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greatly and depends on the cell type and its iron status 
[9]. There are also specializations in the iron metabolism, 
like astrocytes express the ferroxidase ceruloplasmin 
to regulate their iron efflux, whereby oligodendrocytes 
express hephaestin [27]. Oligodendrocytes synthesize 
transferrin, but are lacking a transferrin receptor what 
makes ferritin their main iron source [28].
Tarohda et al. [29] studied age related changes in metal 
concentrations in several brain regions of wistar rats. 
They report increasing iron concentrations during post-
natal development from P1 to P42 reaching adult levels 
before P72. These findings suggest that iron related spe-
cializations and regulatory circuits have essentially devel-
oped within the first two months of age.
Neural cell types are able to individually regulate the 
distribution and storage of iron according to their par-
ticular needs and functions [30]. A cellular iron depletion 
or overload is post-transcriptionally regulated by cyto-
solic iron regulatory proteins that bind to iron-responsive 
elements of the mRNA which alters its translation or 
degradation, thus controlling the amount of specific iron 
proteins for the cellular demand. But it is not the cellular 
regulatory mechanism itself that ensures the cellular iron 
homeostasis. Also cell–cell interactions play a supportive 
or even essential role [5].
For example, oligodendrocytes secrete transferrin to 
other cells, microglia provide iron to oligodendrocytes 
to obviously ensure their demand of iron [31], and also 
astrocytes are known to regulate the transport of iron to 
other cells [32]. Thus, a balanced cellular iron household 
a b
Fig. 4 Intracellular distribution of iron in neurons. a The phosphorus image (P) was used to set regions of interest (ROI, yellow lines in the zoom 
image) for the subcellular quantification of iron in neurons. Nucleoplasm appears less P-rich than cytoplasm and nucleolus. The image shows 
subcortical neurons. b Schematic neuron representing (left) the iron concentration (mM) in the cytoplasm, nucleus and nucleolus and (right) the 
contribution (%) of the compartments to the total iron content of the cell soma calculated for their percentage volume in the cell. Calculation 
includes neurons from the neocortex, substantia nigra, subiculum, and deep cerebellar nuclei. Number of cells: cytoplasm = 14, nucleus = 19, 
nucleolus = 50. Values are given as mean ± SE
Fig. 5 Local iron deposits in neurons. Two element image (red: 
phosphorus, green: iron) of neurons and glial cells. The enlarged 
region shows local iron deposits in the cytoplasm of a neuron
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depends on a regulated intra-as well as intercellular 
uptake, storage, distribution and release of iron. It is com-
prehensible how specialized, precise and organized the 
brain iron metabolism must work, but also how delicate 
it is. Also with age iron redistributes between various 
molecular forms (e.g. ferritin, neuromelanin, transferrin, 
hemosiderin) and the distribution between neurons and 
glial cells changes, but this redistribution is only partly 
understood [5].
Subcompartimental iron content in neurons
The PIXE-analyzed subcellular fractions obtained by dif-
ferential centrifugation of brain homogenate shows a very 
high iron concentration in the microsome fraction. Ribo-
somes, endoplasmic reticulum and vesicles are enriched 
in this fraction, and about 50% of the cellular RNA [33]. 
RNA can directly bind iron and thus may have a contri-
bution to the iron level of this fraction [34]. However, 
most important, also iron-loaded ferritin is enriched in 
the microsome fraction [33, 35]. Since up to 90% of the 
cellular iron in the brain is bound to ferritin [36], the data 
support its well-known function of being the main iron 
storage protein in the cell.
Mitochondria are sites of synthesis of Fe-S clusters 
and heme [37, 38]. A dysfunction of the Fe-S biogenesis 
results in a variety of diseases also affecting the brain with 
commonly developed iron overload in the mitochondria 
[38–41]. However, in healthy rat brain we did not find a 
crucial impact of the mitochondria fraction to the total 
brain iron content, its iron contribution is outshined by 















































Fig. 6 Element maps of glial cells. Light microscopy (LM) and element images (Ni, P, Fe) of the rat cortex specifically stained for oligodendrocytes, 
astrocytes, and microglia. The staining is enhanced with DAB-Ni (black in LM and high concentration in Ni) to identify and visualize the glial cells 
by elemental imaging. Glial iron concentrations were extracted from regions of high Ni concentration, which corresponds to the stained glial 
cells. White arrowheads in the oligodendrocyte and astrocyte images indicate somata of other neuronal/glial cells than the targeted ones (P-rich 
indicates glial cell, but Ni-negative excludes the target cells). Yellow arrowheads in the astrocyte images point to astrocytes where the somata, 
shown by the high Ni concentration, but not the nuclei (P-rich) were contained in the 5µm thin brain section
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the impact of the holo-ferritin enriched in the microsome 
fraction (cytoplasmic ferritin). In neurodegenerative dis-
eases like Alzheimer’s or Parkinson’s, mitochondrial fer-
ritin is increased [42, 43]. But since high mitochondrial 
ferritin levels result in iron deficient phenotypes in the 
cytoplasm, its level is maintained low in normal/healthy 
cells [44]. Our results of an unremarkable iron content 
in the mitochondria fraction of healthy brain are in line 
with these data indicating a low level of mitochondrial 
ferritin with no primary function in iron storage.
Our quantitative imaging of neurons in brain slices 
revealed (Fig.  4), that the nucleolus has a higher iron 
concentration than the nucleus and the cytoplasm 
( p < 0.01 ). The nucleolus was also found to be a hot spot 
for iron in plant cells and in human and rat neurons [45, 
46]. We can corroborate these observations for mamma-
lian brain cells and now provide quantitative data for the 
iron concentration in rat neurons.
The nucleolus is the site for ribosomal RNA (rRNA) 
synthesis and the assembly of the ribosomal subunits 
(overview in [47]). Besides this, the nucleolus has a very 
high concentration in RNA, but also proteins and DNA 
[48, 49]. Thus, its structure is of high optical density in 
conventional optical microscopy. This high density is also 
reflected in quantitative elemental imaging where the 
nucleolus shows high concentrations of elements like P, 
S and Ca. Since the nucleolus is densely packed and iron 
can be a co-factor of nucleolar proteins, or associated 
with rRNA-binding sites, iron is expected to be concen-
trated too. Roschzttardtz and coworkers even speculated 
that iron may be involved in the metabolism of rRNA 
[45].
Additionally, ferritin binds DNA [50] and concentrates 
iron also in the nucleolus. Another contributing source 
might be iron directly bound to RNA. The binding capac-
ity of rRNA is higher than for mRNA or tRNA (shown for 
 Fe2+ by Honda et al. [34]) which leads to higher iron con-
centrations in the nucleolus. For Alzheimer’s disease it is 
shown that rRNA is oxidized by bound redox-active iron 
[34], i.e, the nucleolus might particularly be vulnerable to 
oxidative activity causing neuropathology.
There are also conspicuous local iron deposits in the 
cytoplasm of some neurons. The origin was not further 
investigated, but cytoplasmic accumulations of iron are 
known to occur within lysosomes, since they play a key 
role in iron metabolism and the recycling of iron from 
e.g. mitochondria and ferritin [51].
Estimation of ferritin concentration
A ferritin molecule is able to store up to 5000 iron atoms 
[52]. However, under physiological conditions in the 
human cerebral cortex and cerebellum ferritin was found 
to bind approximately 1500 and 1850 iron atoms, respec-
tively [53].
Based on our data of neuronal iron concentration, one 
can estimate the concentration of ferritin molecules in 
the cytoplasm with a reasonable assumption of the aver-
age number of iron atoms per ferritin molecule with the 
following equation.
f is the fraction of iron bound to ferritin (0.9), cFe the iron 
concentration in milli-molar, NA the Avogadro constant, 
and NFe the average number of iron atoms per ferritin 
molecule. The factor 10−18 results from unit conversions 
to calculate the ferritin concentration nFt in units of mol-
ecules per cubic micrometer. Assuming a load of 2400 
iron atoms per ferritin molecule (midrange of data from 
[22]) and taking the average neuronal iron concentration 
of 0.59 mM (Fig.  3), we calculate 133 ferritin molecules 
per µm3 in rat neurons with an uncertainty of ± 25 (based 
on estimated uncertainties of 0.1, 0.06 mM , and 250 for 
f, cFe , and NFe , respectively). This density is in agreement 
with the results from Zhang et al. [22] who quantitatively 
analyzed the Fe-load and distribution of ferritin in and 
around axons in mouse brain slices. They report for wild-
type mice the number of iron atoms per ferritin mol-
ecule to be in the range from 1200 to 3600 and average 
densities of 130 and 133 ferritin molecules per µm3 (two 
tomograms analyzed). The concentration was relatively 
uniform in regions inside and outside axons.
Going beyond comparing our estimate of ferritin con-
centration with the matching result from Zhang et  al. 
[22], we want to propose Eq. 1 as a reasonable estimation 
for ferritin concentrations based on measured total iron 
concentrations and the iron load as a parameter. Table 1 
gives, for the here presented results, the estimates of fer-
ritin concentrations in neurons and glial cells for three 










Table 1 Estimated concentrations of  ferritin molecules, 
derived from  measured iron concentrations with  the  iron 
load parameter NFe in  Fe atoms per  ferritin molecule (Fe/
Ft) according Eq. 1










Neurons 0.57 270 180 130
Astrocytes 1.29 580 390 290
Microglia 1.76 790 530 400
Oligodendrocytes 3.05 1380 920 690
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Relevance in neuropathology and therapy
Failures in iron homeostasis mechanisms may be a 
pathological condition that causes oxidative stress and 
subsequently neurodegeneration. It is still not clear 
whether the observed excessive Fe accumulation in the 
brain is always the initial event or a consequence of the 
disease process [54, 55]. However, a better understand-
ing of iron accumulation in brain disorders has thera-
peutic implications. Iron chelators are being explored 
in pre-clinical models and clinical trials for several 
diseases associated with brain iron imbalance, includ-
ing Parkinson’s disease, Alzheimer’s disease, Friedre-
ich’s ataxia and amyotrophic lateral sclerosis [3, 56–59]. 
Especially promising results in clinical studies were 
achieved with iron-chelating drugs [60–62]. However, 
currently, the clinical effect of an iron chelation ther-
apy still remains unclear [9, 58, 62, 63]. Not only the 
differences among the brain regions and the cell types 
involved in each disorder makes it unlikely to succeed 
as a general strategy, but also the cellular differences in 
iron concentrations and distributions presented in this 
study suggest differences in functionality and patholog-
ical potential. A cell-specific misregulation or misloca-
tion would either result in local anemia and functional 
deficiency, or in iron-induced oxidative stress [30]. This 
calls for customized iron chelators that are designed to 
specifically target only relevant cell types.
Conclusions
Based on the assumption that the glial cells’ functions 
and physiology are similar among the brain regions, we 
conclude that glial cells are the most iron-rich cells in 
the brain, from which oligodendrocytes have the high-
est concentration. Any study which measures iron con-
tent in the brain with lower than cellular resolution 
should not only focus on neurons, but also consider 
glial cell iron contributions. Similarly, imbalances in 
iron homeostasis that lead to neurodegeneration may 
not only be localized in neurons but also, or even in the 
first place, in glial cells.
Since the majority of brain iron is bound to ferritin, it 
is feasible to estimate the ferritin concentration based 
on reasonable assumption of the average ferritin load-
ing and measured iron concentrations.
Methods
For the study two months old Wistar rats (Rattus nor-
vegicus f. domestica) were used, three male rats for quan-
titative mapping and analysis of the intracellular iron, 
and one female rat for the qualitative analysis of iron in 
subcellular fractions. The animals were obtained from 
and housed at the animal care facility of the Paul Flech-
sig Institute for Brain Research of Leipzig University. 
They were kept on a 12/12h dark/light cycle with free 
access to food and water. Experiments were carried out 
in accordance to the guidelines of the European Council 
Directive (1986; 86/609/EEC) and with approval by the 
local authorities. All animals were anesthetized in a 5-L 
anaesthesia chamber by opening a 100% CO2 influx to a 
flow rate of 1 L/min. After confirmation of unconscious-
ness by loss of the tail clamp response the animals were 
quickly sacrificed by decapitation or perfusion.
Iron content in subcellular fractions of brain homogenate
Differential centrifugation
Differential centrifugation was used to separate and 
enrich subcellular particles from brain homogenate. 
Therefore, we homogenized one complete snap frozen rat 
neocortex in 0.25 M saccharose solution (final dilution of 
10%) with a Dounce homogenizer on ice. The homogen-
ate was centrifuged (Sorvall Combi Plus, DuPont, USA) 
according to the protocol given in Fig. 7. For the nucleus 
and the mitochondria fraction the centrifugation step 
was performed twice and the first and second pellets 
were pooled of each fraction. The fractions were verified 
by transmission electron microscopy.
The following subcellular fractions were obtained: (1) 
nucleus fraction containing cell nuclei and myelin frag-
ments, (2) mitochondria fraction enriched in mitochon-
dria, synaptosomes, Golgi bodies, peroxisomes and 
lysosomes, and (3) microsome fraction consisting of 
plasma membranes, ribosomes, endoplasmic reticulum 
and vesicles. (4) The supernatant of the differential cen-
trifugation, was referred to as cytosolic fraction.
Fig. 7 Differential centrifugation protocol. Differential centrifugation protocol for fresh neocortex homogenate in 0.25 M saccharose solution to 
obtain the following subcellular fractions: nucleus fraction (blue), mitochondria fraction (green) and microsome fraction (red). The enrichment 
of the target particles is verified by transmission electron microscopy. The nucleus fraction contains cell nuclei (highlighted in blue, nucleolus in 
darker blue) as well as myelin fragments as seen at the very bottom of the picture. The mitochondria fraction is enriched in numerous mitochondria 
(highlighted in green), but also synaptosomes (highlighted in yellow), Golgi complexes (highlighted in light blue) and lysosomes (highlighted in 
red). The microsomal fraction contains microsomes (highlighted in red, summarizing vesicles, plasma membranes, ribosomes and endoplasmic 
reticulum)
(See figure on next page.)
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Transmission electron microscopy
10µL of each fraction were fixed in 4% formaldehyde and 
2% glutaraldehyde in 0.1 M phosphate-buffered saline 
(PBS, pH 7.4) for 30 min at room temperature, washed 
twice in Aqua bidest by centrifugation, embedded in 3% 
agarose gel, contrasted/fixed in 1% osmium tetroxide 
(Merck) for 1 h at 4 ◦C , rinsed thoroughly in PBS, dehy-
drated in a series of acetone and contrasted with 1% ura-
nyl acetate (Merck) in 70% acetone for 45 min at room 
temperature. For sectioning the samples were embedded 
in Durcupan araldite casting resin M (Fluka) accord-
ing to a standard embedding procedure. Semithin sec-
tions (500 nm) were cut on an ultramicrotome (Reichert) 
and stained with toluidine blue for initial observation. 
Ultrathin sections (50 nm) were cut and examined by 
transmission electron microscopy (TEM) (Zeiss LEO 912 
Omega and Zeiss Libra 120). All fractions were proven to 
be enriched in their specific subcellular particles (Fig. 7).
PIXE spectrometry
In order to analyze the same volume of each subcel-
lular fraction with particle induced X-ray emission, 
5µL were dropped on a 2 mm× 2 mm wide and 200 
nm thin Si3N4 membran (Silson Ltd, UK) and air-dried. 
A 2.25 MeV proton beam was scanned in a square of 
1.6 mm× 1.6 mm over the center of the dried droplet 
while the X-ray spectrum was collected and normalized 
by the charge, i.e. by the number of exciting protons. 
Since the peak areas of the characteristic X-ray lines are 
a measure of the elemental contents in the equal-volume 
droplets, the charged-normalized peak areas were used 
to calculate the proportion of total iron of the individual 
subcellular fractions.
Quantitative elemental imaging of neurons and glial cells 
in brain slices
Preparation of brain sections
Rats ( n = 3 ) were sacrificed with CO2 and transcardially 
perfused with saline (0.9% NaCl)/0.1% heparin to elimi-
nate hem-iron. Further, a fixative solution of 4% formal-
dehyde and 0.1% glutaraldehyde in 0.1 M PBS (pH 7.4) 
was transcardially perfused for 30 min.
Brains were removed from the scull, cut into three cor-
onal sections using a scalpel, and post-fixated in the same 
fixative solution overnight at room temperature. After 
dehydration in increasing ethanol concentrations and 
followed repletion in methylbenzoate, the samples were 
embedded in paraffin. Frontal sections of 5µm thickness 
were cut containing the neocortex (Bregma 4.1 mm ), 
subiculum, substantia nigra (Bregma 4.1 mm ) and deep 
cerebellar nuclei (Bregma 10.8 mm ). The sections were 
transferred to  Superfrost® glass slides, deparaffinized 
with xylene, rehydrated in decreasing concentrations of 
ethanol and transferred into PBS (pH 7.4).
Immunohistochemistry
Brain slices for glial cell analysis were immunohisto-
chemically stained at 4 ◦C over night with polyclonal 
rabbit IgG against glial fibrillary acidic protein (GFAP, 
AB_10013482, Dako, 1:1000) for astrocytes; ionized cal-
cium binding adaptor molecule 1 (IBA-1, AB_839506, 
Wako, 1:500) for microglia; or oligodendrocyte-specific 
protein (OSP, AB_2276205, abcam, 1:200) for oligoden-
drocytes. Brain slices were washed in PBS (pH 7.4) and 
were then incubated with the secondary antibody (bio-
tin-conjugated donkey anti-rabbit IgG, AB_2340585, 
JacksonImmunoRes, 1:1000). Further, all brain slices 
were washed in PBS (pH 7.4), rinsed in Tris-HCl (pH 8) 
and were then incubated for 1 h at room temperature 
with peroxidase-conjugated streptavidin  (ExtrAvidin®, 
SCR_013728, Sigma, 1:1000) to reveal the antibody bind-
ing sites. The staining was enhanced by 3,3′-diaminoben-
zidine (DAB, Sigma) and Ni (nickel ammonium sulphate, 
purity grade 99.999%, Sigma) in Tris-HCl (pH 8). Brain 
slices were finally rinsed in Tris-HCl and PBS again. Ni is 
used as enhancer, because it is visible with light micros-
copy due to its black precipitate, and in elemental imag-
ing due to its characteristic X-ray emission [64]. The 
Ni-staining was proven to not introduce any significant 
impurities, especially to not alter the distribution and 
concentration of iron [64–66].
Embedding for µ PIXE analysis
For quantitative elemental imaging by scanning particle 
induced X-ray emission ( µPIXE), the brain sections, still 
on  Superfrost® object slides, were covered with a small 
droplet of mounting medium (DePeX, Serva) that was 
spread out by shortly covering the sections with another 
object slide. Holding the object slide sandwich verti-
cally, whereby the cover slide was allowed to move freely 
downward by gravity, a thin layer of embedding medium 
was produced after the cover slide eventually slipped 
off. After 24 h of drying at room temperature a rectan-
gular area of 20 mm× 15 mm containing the brain sec-
tion was cut out, peeled off, and attached to aluminum 
frames using double sided adhesive carbon tape. Thus, 
free-standing 15µm thick DePeX foils were prepared that 
had the brain sections embedded, but not covered on the 
surface later facing the X-ray detector.
Light microscopic images (Olympus BXiS, Germany) 
of each framed brain slice were done for orientation and 
re-recognition of the cells within the PIXE element maps.
Additionally, fresh rat brain was snap frozen in liquid 
nitrogen chilled isopentane to prepare 15µm thick cry-
osections (Bregma 4.1 mm ) using a cryostat microtome 
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(HM 500 O, Microm). The sections were sandwiched 
between two formvar foils (Serva) as a support for ele-
mental analysis. The sections were dried at − 36 ◦C in 
the cryostat to prevent potential elemental redistribution 
caused by thawing.
µ PIXE analysis
Quantitative elemental imaging and analysis were done 
with a 1µm proton beam of 2.25 MeV energy using the 
high energy ion nanoprobe LIPSION at Leipzig Uni-
versity, Faculty of Physics and Geosciences, [66, 67]. 
The proton beam was scanned over the brain sections 
while the induced X-rays emitted from the sample were 
recorded. This technique is called PIXE, the prefix “ µ ” 
in µPIXE refers to the capability of microscopic ele-
ment imaging using a scanned focused beam. Quantita-
tive analysis is based on (1) spectral deconvolution by 
least squares fitting of element peaks and background, 
(2) calculated yield to each element from fundamental 
parameters for X-ray production and matrix effects, and 
(3) the theoretical description of the detectors responses, 
geometric parameters, and absolute efficiencies [68]. The 
correct description of the detector system is verified by 
analysis of certified reference standards [69].
From the recorded X-rays, tagged with the position, 
overlap-free and quantitative element images were cre-
ated using dynamic analysis [70], which is part of the 
GeoPIXE software. GeoPIXE also provides a wide range 
of graphical tools that were used to encircle the regions 
of interest in the images and determine the average ele-
mental concentrations therein. Since the MeV-protons 
cause relatively low background radiation in the element 
characteristic X-ray spectrum, the minimum detection 
limits, especially for elements of atomic number between 
Z = 21 . . . 30 , thus also for iron, are at µg/g-level which 
corresponds to concentrations around 10µM.
Statistics
The significance of differences between elemental con-
centrations of neurons and glia cells was tested using the 
t-test with unequal sample size of cells from three rats. 
The test of common distribution was performed with a 
Q–Q-plot. µPIXE data between the three rats did not dif-
fer significantly (t-test, p < 0.05).
One rat was used for the differential centrifugation. 
Therefore, no statistical test was performed. The differ-
ence between the microsome and the other fractions is 
with a factor of eight large enough to justify the use of a 
single rat.
Abbreviations
AAS: atomic absorption spectroscopy; DAB: 3,3′-diaminobenzidine; Ft: ferritin; 
LA-ICP-MS: laser ablation inductively-coupled plasma mass spectrometry; 
LM: light microscopy; MRI: magnetic resonance imaging; NBIA: neurodegen-
eration with brain iron accumulation; PBS: phosphate-buffered saline; PIXE: 
particle induce X-ray emission; µPIXE: scanning particle induce X-ray emission; 
SRXRF: synchrotron radiation X-ray fluorescence; TEM: transmission electron 
microscopy.
Acknowledgements
We thank Dr. C. Jäger and Ms. H. Gruschka for excellent support in preparation 
and immunohistochemical staining. We acknowledge support from the Ger-
man Research Foundation and Leipzig University within the program of Open 
Access Publishing.
Authors’ contributions
MM, AR and TR conceived the study. All authors (TA and AR leading) contrib-
uted to the funding of the study. AR carried out differential centrifugation, 
immunohistochemistry, light and electron microscopy. AR and TR carried out 
the PIXE experiments and data analysis. MM supervised planning the experi-
ments, sample preparation and staining. AR, MM, TA and TR interpreted the 
results. AR and TR prepared the figures. AR, TR and MM wrote the paper. All 
authors read and approved the final manuscript.
Funding
This study was supported by the German Research Foundation by providing 
a scholarship for A.R. within the interdisciplinary Research Training Group 
1097 “INTERNEURO” (PI: T.A.; Co-PI: M.M., T.R.). The Medical Faculty of Leipzig 
University with support from the Federal Ministry of Education and Research 
funded the PIXE detector within the formel.1 Young Scientist Award (PI: A.R.). 
The Saxon Ministry of the Arts and Sciences and the DFG provided funding for 
the TEM (PI: J.S.).
Availability of data and materials
The datasets analyzed during the current study are not publicly available yet, 
because results of another aspect are included that we intend to submit later 
on. However, they are available from the corresponding author on reasonable 
request.
Ethics approval and consent to participate
The use of the animals for the experiments and the methods were carried out 
in accordance with approved guidelines and had been approved by the local 
authorities Saxony (Landesdirektion Sachsen, Leipzig, Germany) based on the 
recommendation of the advisory Ethics Commission (T61/01, T63/09; Landes-
direktion Sachsen, Leipzig, Germany). The treatment of the animals was carried 
out in accordance with the then in force European Council Directive 86/609/
EEC and with the Directive 2003/65/EC (on the amendment of the former) 




The authors declare that they have no competing interests.
Author details
1 Faculty of Veterinary Medicine, Leipzig University, An den Tierkliniken 43, 
04103 Leipzig, Germany. 2 Paul Flechsig Institute, Liebigstr. 58, 04103 Leipzig, 
Germany. 3 Max Planck Institute, Stephanstr. 1A, 04103 Leipzig, Germany. 
4 Felix Bloch Institute, Linnéstr. 5, 04103 Leipzig, Germany. 
Received: 1 March 2019   Accepted: 21 May 2019
References
 1. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH. Altered brain metab-
olism of iron as a cause of neurodegenerative diseases? J Neurochem. 
1994;63(3):793–807. https ://doi.org/10.1046/j.1471-4159.1994.63030 
793.x.
Page 13 of 14Reinert et al. BMC Neurosci           (2019) 20:25 
 2. Thompson KJ, Shoham S, Connor JR. Iron and neurodegenerative dis-
orders. Brain Res Bull. 2001;55(2):155–64. https ://doi.org/10.1016/S0361 
-9230(01)00510 -X.
 3. Hare DJ, Ayton S, Bush AI, Lei P. A delicate balance: iron metabolism 
and diseases of the brain. Front Aging Neurosci. 2013;5:34. https ://doi.
org/10.3389/fnagi .2013.00034 .
 4. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and 
neurodegenerative disorders. Mol Cell Biochem. 2010;345(1–2):91–104. 
https ://doi.org/10.1007/s1101 0-010-0563-x.
 5. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron 
in brain ageing and neurodegenerative disorders. Lancet Neurol. 
2014;13(10):1045–60. https ://doi.org/10.1016/S1474 -4422(14)70117 -6.
 6. Chen J-H, Singh N, Tay H, Walczyk T. Imbalance of iron influx and efflux 
causes brain iron accumulation over time in the healthy adult rat. Metal-
lomics. 2014;6(8):1417–26. https ://doi.org/10.1039/c4mt0 0054d .
 7. Genoud S, Roberts BR, Gunn AP, Halliday GM, Lewis SJG, Ball HJ, Hare 
DJ, Double KL. Subcellular compartmentalisation of copper, iron, 
manganese, and zinc in the Parkinson’s disease brain. Metallomics. 
2017;9(10):1447–55. https ://doi.org/10.1039/c7mt0 0244k .
 8. Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. 
Neurobiol Dis. 2012;46(1):1–18. https ://doi.org/10.1016/j.nbd.2011.12.054.
 9. Rouault TA. Iron metabolism in the CNS: implications for neurode-
generative diseases. Nat Rev Neurosci. 2013;14(8):551–64. https ://doi.
org/10.1038/nrn34 53.
 10. Riemer J, Hoepken HH, Czerwinska H, Robinson SR, Dringen R. Colorimet-
ric ferrozine-based assay for the quantitation of iron in cultured cells. Anal 
Biochem. 2004;331(2):370–5. https ://doi.org/10.1016/j.ab.2004.03.049.
 11. Que EL, Domaille DW, Chang CJ. Metals in neurobiology: probing 
their chemistry and biology with molecular imaging. Chem Rev. 
2008;108(5):1517–49. https ://doi.org/10.1021/cr078 203u.
 12. Savory J, Herman M. Advances in instrumental methods for the measure-
ment and speciation of trace metals. Ann Clin Lab Sci. 1999;29(2):118–26. 
https ://doi.org/10.1042/BJ200 51496 .
 13. McRae R, Bagchi P, Sumalekshmy S, Fahrni CJ. In situ imaging of metals 
in cells and tissues. Chem Rev. 2009;109(10):4780–827. https ://doi.
org/10.1021/cr900 223a.
 14. Bourassa MW, Miller LM. Metal imaging in neurodegenerative diseases. 
Metallomics. 2012;4:721–38. https ://doi.org/10.1039/C2MT2 0052J .
 15. Ortega R, Cloetens P, Devès G, Carmona A, Bohic S. Iron storage within 
dopamine neurovesicles revealed by chemical nano-imaging. PLoS ONE. 
2007;2(9):925. https ://doi.org/10.1371/journ al.pone.00009 25.
 16. Hare DJ, Lei P, Ayton S, Roberts BR, Grimm R, George JL, Bishop DP, Beavis 
AD, Donovan SJ, McColl G, Volitakis I, Masters CL, Adlard PA, Cherny RA, 
Bush AI, Finkelstein DI, Doble PA. An iron–dopamine index predicts risk of 
parkinsonian neurodegeneration in the substantia nigra pars compacta. 
Chem Sci. 2014;5(4):2160–9. https ://doi.org/10.1039/c3sc5 3461h .
 17. Hill JM, Switzer RC. The regional distribution and cellular localization 
of iron in the rat brain. Neuroscience. 1984;11(3):595–603. https ://doi.
org/10.1016/0306-4522(84)90046 -0.
 18. Connor JR, Menzies SL. Relationship of iron to oligondendrocytes and 
myelination. Glia. 1996;17(2):83–93. https ://doi.org/10.1002/(SICI)1098-
1136(19960 6)17:2%3c83::AID-GLIA1 %3d3.0.CO;2-7.
 19. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR. Oligodendrocytes 
and myelination: the role of iron. Glia. 2009;57(5):467–78. https ://doi.
org/10.1002/glia.20784 .
 20. Gerber MR, Connor JR. Do oligodendrocytes mediate iron regulation in 
the human brain? Ann Neurol. 1989;26(1):95–8. https ://doi.org/10.1002/
ana.41026 0115.
 21. Liu Y, Zhou J. Oligodendrocytes in neurodegenerative diseases. Front Biol. 
2013;8(2):127–33. https ://doi.org/10.1007/s1151 5-013-1260-4.
 22. Zhang P, Land W, Lee S, Juliani J, Lefman J, Smith SR, Germain D, Kessel M, 
Leapman R, Rouault TA, Subramaniam S. Electron tomography of degen-
erating neurons in mice with abnormal regulation of iron metabolism. J 
Struct Biol. 2005;150(2):144–53. https ://doi.org/10.1016/j.jsb.2005.01.007.
 23. Hoepken HH, Korten T, Robinson SR, Dringen R. Iron accumulation, 
iron-mediated toxicity and altered levels of ferritin and transferrin 
receptor in cultured astrocytes during incubation with ferric ammo-
nium citrate. J Neurochem. 2004;88(5):1194–202. https ://doi.org/10.104
6/j.1471-4159.2003.02236 .x.
 24. Lodish HF. Molecular cell biology. 6th ed. New York: W.H. Freeman; 2008.
 25. Dringen R, Hamprecht B. Glutathione restoration as indicator for cellular 
metabolism of astroglial cells. Dev Neurosci. 1998;20(4–5):401–7.
 26. Bishop G, Dang T, Dringen R, Robinson S. Accumulation of non-trans-
ferrin-bound iron by neurons, astrocytes, and microglia. Neurotox Res. 
2011;19(3):443–51. https ://doi.org/10.1007/s1264 0-010-9195-x.
 27. Schulz K, Vulpe CD, Harris LZ, David S. Iron efflux from oligodendro-
cytes is differentially regulated in gray and white matter. J Neurosci. 
2011;31(37):13301–11. https ://doi.org/10.1523/JNEUR OSCI.2838-11.2011.
 28. Todorich B, Zhang X, Connor JR. H-ferritin is the major source of iron 
for oligodendrocytes. Glia. 2011;59(6):927–35. https ://doi.org/10.1002/
glia.21164 .
 29. Tarohda T, Yamamoto M, Amamo R. Regional distribution of manganese, 
iron, copper, and zinc in the rat brain during development. Anal Bioanal 
Chem. 2004;380(2):240–6. https ://doi.org/10.1007/s0021 6-004-2697-8.
 30. Rouault TA, Cooperman S. Brain iron metabolism. Semin Pediatr Neurol. 
2006;13(3):142–8. https ://doi.org/10.1016/j.spen.2006.08.002.
 31. Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR. Cellular iron 
status influences the functional relationship between microglia and 
oligodendrocytes. Glia. 2006;54(8):795–804. https ://doi.org/10.1002/
glia.20416 .
 32. Dringen R, Bishop G, Koeppe M, Dang T, Robinson S. The pivotal role 
of astrocytes in the metabolism of iron in the brain. Neurochem Res. 
2007;32(11):1884–90. https ://doi.org/10.1007/s1106 4-007-9375-0.
 33. Moulé Y, Rouiller C, Chauveau J. A biochemical and morphological study 
of rat liver microsomes. J Biophys Biochem Cytol. 1960;7(3):547–57.
 34. Honda K, Smith MA, Zhu X, Baus D, Merrick WC, Tartakoff AM, Hattier T, 
Harris PL, Siedlak SL, Fujioka H, Liu Q, Moreira PI, Miller FP, Nunomura A, 
Shimohama S, Perry G. Ribosomal rna in alzheimer disease is oxidized by 
bound redox-active iron. J Biol Chem. 2005;280(22):20978–86. https ://doi.
org/10.1074/jbc.M5005 26200 .
 35. Thomas CE, Aust SD. Rat liver microsomal NADPH-dependent release 
of iron from ferritin and lipid peroxidation. J Free Radic Biol Med. 
1985;1(4):293–300.
 36. Double KL, Maywald M, Schmittel M, Riederer P, Gerlach M. In vitro 
studies of ferritin iron release and neurotoxicity. J Neurochem. 
1998;70(6):2492–9. https ://doi.org/10.1046/j.1471-4159.1998.70062 492.x.
 37. Rouault TA, Tong W-H. Iron–sulphur cluster biogenesis and mitochondrial 
iron homeostasis. Nat Rev Mol Cell Biol. 2005;6(4):345–51. https ://doi.
org/10.1038/nrm16 20.
 38. Lill R, Hoffmann B, Molik,S, Pierik AJ, Rietzschel N, Stehling O, Uzarska MA, 
Webert H, Wilbrecht C, Mühlenhoff U. The role of mitochondria in cellular 
iron–sulfur protein biogenesis and iron metabolism. Biochim Biophys 
Acta (BBA) Mol Cell Res. 2012;1823(9):1491–508. https ://doi.org/10.1016/j.
bbamc r.2012.05.009.
 39. Horowitz MP, Greenamyre JT. Mitochondrial iron metabolism and its role 
in neurodegeneration. J Alzheimer’s Dis JAD. 2010;20(Suppl 2):551–68. 
https ://doi.org/10.3233/JAD-2010-10035 4.
 40. Rouault TA. Biogenesis of iron–sulfur clusters in mammalian cells: 
new insights and relevance to human disease. Dis Models Mech. 
2012;5(2):155–64. https ://doi.org/10.1242/dmm.00901 9.
 41. Mena NP, Urrutia PJ, Lourido F, Carrasco CM, Núñez MT. Mitochondrial 
iron homeostasis and its dysfunctions in neurodegenerative disorders. 
Mitochondrion. 2015;21:92–105.
 42. Yang H, Yang M, Guan H, Liu Z, Zhao S, Takeuchi S, Yanagisawa D, Tooy-
ama I. Mitochondrial ferritin in neurodegenerative diseases. Neurosci Res. 
2013;77(1):1–7. https ://doi.org/10.1016/j.neure s.2013.07.005.
 43. Liddell JR, White AR. Nexus between mitochondrial function, iron, copper 
and glutathione in Parkinson’s disease. Neurochem Int. 2018;117:126–38. 
https ://doi.org/10.1016/j.neuin t.2017.05.016.
 44. Drysdale J, Arosio P, Invernizzi R, Cazzola M, Volz A, Corsi B, Biasiotto G, 
Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells 
Mol Dis. 2002;29(3):376–83.
 45. Roschzttardtz H, Grillet L, Isaure M-P, Conéjéro G, Ortega R, Curie 
C, Mari S. Plant cell nucleolus as a hot spot for iron. J Biol Chem. 
2011;286(32):27863–6. https ://doi.org/10.1074/jbc.C111.26972 0.
 46. Sukhorukova EG, Grigoriev IP, Kirik OV, Alekseeva OS, Korzhevskii DE. Intra-
nuclear iron localization in mammalian brain neurons. J Evol Biochem 
Physiol. 2013;49(3):370–2.
 47. Pederson T. The nucleolus. Cold Spring Harbor Perspect Biol. 
2011;3(3):a000638. https ://doi.org/10.1101/cshpe rspec t.a0006 38.
Page 14 of 14Reinert et al. BMC Neurosci           (2019) 20:25 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 48. Stern H, Johnston FB, Setterfield G. Some chemical properties of isolated 
pea nucleoli. J Biophys Biochem Cytol. 1959;6(1):57–60. https ://doi.
org/10.1083/jcb.6.1.57.
 49. Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, Steen H, Mann M, 
Lamond AI. Directed proteomic analysis of the human nucleolus. Curr 
Biol. 2002;12(1):1–11.
 50. Surguladze N, Thompson KM, Beard JL, Connor JR, Fried MG. Interactions 
and reactions of ferritin with DNA. J Biol Chem. 2004;279(15):14694–702. 
https ://doi.org/10.1074/jbc.M3133 48200 .
 51. Kurz T, Eaton JW, Brunk UT. The role of lysosomes in iron metabolism 
and recycling. Int J Biochem Cell Biol. 2011;43(12):1686–97. https ://doi.
org/10.1016/j.bioce l.2011.08.016.
 52. Jian N, Dowle M, Horniblow RD, Tselepis C, Palmer RE. Morphology of 
the ferritin iron core by aberration corrected scanning transmission 
electron microscopy. Nanotechnology. 2016;27(46):46LT02. https ://doi.
org/10.1088/0957-4484/27/46/46LT0 2.
 53. Dedman DJ, Treffry A, Candy J, Taylor G, Morris C, Bloxham C, Perry R, 
Edwardson J, Harrison P. Iron and aluminium in relation to brain ferritin 
in normal individuals and Alzheimer’s-disease and chronic renal-dialysis 
patients. Biochem J. 1992;287:509–14.
 54. Morawski M, Meinecke C, Reinert T, Dörffel AC, Riederer P, Arendt T, Butz 
T. Determination of trace elements in the human substantia nigra. Nucl 
Instrum Methods Phys Res Sect B Beam Interact Mater At. 2005;231(1–
4):224–8. https ://doi.org/10.1016/j.nimb.2005.01.061.
 55. Batista-Nascimento L, Pimentel C, Andrade Menezes R, Rodrigues-
Pousada C. Iron and neurodegeneration: from cellular homeostasis to dis-
ease. Oxid Med Cell Longev. 2012;. https ://doi.org/10.1155/2012/12864 7.
 56. Singh N, Haldar S, Tripathi AK, Horback K, Wong J, Sharma D, Beserra A, 
Suda S, Anbalagan C, Dev S, et al. Brain iron homeostasis: from molecular 
mechanisms to clinical significance and therapeutic opportunities. 
Antioxid Redox Signal. 2014;20(8):1324–63. https ://doi.org/10.1089/
ars.2012.4931.
 57. Ward RJ, Dexter DT, Crichton RR. Neurodegenerative diseases and thera-
peutic strategies using iron chelators. J Trace Elem Med Biol. 2015;31:267–
73. https ://doi.org/10.1016/j.jtemb .2014.12.012.
 58. Dusek P, Schneider SA, Aaseth J. Iron chelation in the treatment of neuro-
degenerative diseases. J Trace Elem Med Biol. 2016;38:81–92. https ://doi.
org/10.1016/j.jtemb .2016.03.010.
 59. Nuñez MT, Chana-Cuevas P. New perspectives in iron chelation therapy 
for the treatment of neurodegenerative diseases. Pharmaceuticals (Basel). 
2018;. https ://doi.org/10.3390/ph110 40109 .
 60. Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux 
A, Ryckewaert G, Garçon G, Rouaix N, et al. Targeting chelatable iron as 
a therapeutic modality in Parkinson’s disease. Antioxid Redox Signal. 
2014;21(2):195–210. https ://doi.org/10.1089/ars.2013.5593.
 61. Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux 
C, Petrault M, Gouel F, Jonneaux A, Dutheil M, Lachaud C, Lopes R, 
Kuchcinski G, Auger F, Kyheng M, Duhamel A, Pérez T, Pradat PF, Blasco 
H, Veyrat-Durebex C, Corcia P, Oeckl P, Otto M, Dupuis L, Garçon G, 
Defebvre L, Cabantchik ZI, Duce J, Bordet R, Devos D. Could conservative 
iron chelation lead to neuroprotection in amyotrophic lateral sclero-
sis? Antioxid Redox Signal. 2018;29(8):742–8. https ://doi.org/10.1089/
ars.2017.7493.
 62. Martin-Bastida A, Ward RJ, Newbould R, Piccini P, Sharp D, Kabba C, Patel 
MC, Spino M, Connelly J, Tricta F, Crichton RR, Dexter DT. Brain iron chela-
tion by deferiprone in a phase 2 randomised double-blinded placebo 
controlled clinical trial in Parkinson’s disease. Sci Rep. 2017;7(1):1398. 
https ://doi.org/10.1038/s4159 8-017-01402 -2.
 63. Stankiewicz JM, Neema M, Ceccarelli A. Iron and multiple sclerosis. 
Neurobiol Aging. 2014;35(Supplement 2):51–8. https ://doi.org/10.1016/j.
neuro biola ging.2014.03.039.
 64. Morawski M, Reinert T, Meinecke C, Arendt T, Butz T. Antibody meets the 
microbeam—or how to find neurofibrillary tangles. Nucl Instrum Meth-
ods Phys Res B Beam Interact Mater At. 2005;231(1–4):229–33. https ://doi.
org/10.1016/j.nimb.2005.01.062.
 65. Morawski M, Reinert T, Meyer-Klaucke W, Wagner FE, Tröger W, Reinert 
A, Jäger C, Arendt T. Ion exchanger in the brain: quantitative analysis of 
perineuronally fixed anionic binding sites suggests diffusion barriers with 
ion sorting properties. Sci Rep. 2015;5:16471. https ://doi.org/10.1038/
srep1 6471.
 66. Fiedler A, Reinert T, Morawski M, Brückner G, Arendt T, Butz T. Intracellular 
iron concentration of neurons with and without perineuronal nets. Nucl 
Instrum Methods Phys Res B Beam Interact Mater At. 2007;260(1):153–8. 
https ://doi.org/10.1016/j.nimb.2007.02.069.
 67. Reinert T, Andrea T, Barapatre N, Hohlweg M, Koal T, Larisch W, Reinert A, 
Spemann D, Vogt J, Werner R, Butz T. Biomedical research at lipsion—pre-
sent state and future developments. Nucl Instrum Methods Phys Res B 
Beam Interact Mater At. 2011;269(20):2254–9. https ://doi.org/10.1016/j.
nimb.2011.02.071.
 68. Ryan CG. PIXE and the nuclear microprobe: tools for quantitative imaging 
of complex natural materials. Nucl Instrum Methods Phys Res B Beam 
Interact Mater At. 2011;269(20):2151–62. https ://doi.org/10.1016/j.
nimb.2011.02.046.
 69. Mulware SJ, Baxley JD, Rout B, Reinert T. Efficiency calibration of an HPGe 
X-ray detector for quantitative PIXE analysis. Nucl Instrum Methods Phys 
Res B Beam Interact Mater At. 2014;332:95–8. https ://doi.org/10.1016/j.
nimb.2014.02.037.
 70. Ryan CG, van Achterbergh E, Jamieson DN, Churms CL. Overlap corrected 
on-line PIXE imaging using the proton microprobe. Nucl Instrum Meth-
ods Phys Res B Beam Interact Mater At. 1996;109(110):154–60. https ://doi.
org/10.1016/0168-583X(95)00898 -5.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
